The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice.

Details

Language :

English

ISSN :

01433636

Volume :

45

Issue :

1

Database :

Complementary Index

Journal :

Nuclear Medicine Communications

Publication Type :

Academic Journal

Accession number :

174827582

Full Text :

https://doi.org/10.1097/MNM.0000000000001775